Circulation. 2018 May 22;137(21):e661-e689. doi: 10.1161/CIR.0000000000000567. Epub 2018 Apr 19.
Intracranial endovascular interventions provide effective and minimally invasive treatment of a broad spectrum of diseases. This area of expertise has continued to gain both wider application and greater depth as new and better techniques are developed and as landmark clinical studies are performed to guide their use. Some of the greatest advances since the last American Heart Association scientific statement on this topic have been made in the treatment of ischemic stroke from large intracranial vessel occlusion, with more effective devices and large randomized clinical trials showing striking therapeutic benefit. The treatment of cerebral aneurysms has also seen substantial evolution, increasing the number of aneurysms that can be treated successfully with minimally invasive therapy. Endovascular therapies for such other diseases as arteriovenous malformations, dural arteriovenous fistulas, idiopathic intracranial hypertension, venous thrombosis, and neoplasms continue to improve. The purpose of the present document is to review current information on the efficacy and safety of procedures used for intracranial endovascular interventional treatment of cerebrovascular diseases and to summarize key aspects of best practice.
颅内血管内介入治疗为广泛的疾病提供了有效且微创的治疗手段。随着新技术的发展和里程碑式的临床研究来指导其应用,这一专业领域不断得到更广泛的应用和更深入的发展。自上次美国心脏协会关于该主题的科学声明以来,该领域取得了一些最大的进展,尤其是在治疗因大颅内血管阻塞引起的缺血性中风方面,更有效的设备和大型随机临床试验显示出显著的治疗益处。脑动脉瘤的治疗也取得了实质性的进展,增加了可以通过微创治疗成功治疗的动脉瘤数量。动静脉畸形、硬脑膜动静脉瘘、特发性颅内高压、静脉血栓形成和肿瘤等其他疾病的血管内治疗也在不断改进。本文件的目的是回顾目前关于用于治疗脑血管疾病的颅内血管内介入治疗的程序的疗效和安全性的信息,并总结最佳实践的关键方面。